Director of Bayamo’s Liquid Oral
Pharmaceutical Labs, Luis Alarcon Camejo said today the
growth in production meets the commitments made by the country with
the regional group that
includes Venezuela, Ecuador, Bolivia, Saint Vincent and the
Grenadines, Honduras, Dominica,
and Antigua and Barbuda.
Alarcon Camejo, told ACN that the labs’ production line includes
syrups, solutions, drops,
suspensions and emulsions.
The laboratory, with 415 workers most of them women, produces the
liquid oral medicines
demanded in the country to avoid the import of 51 products and meets
ALBA’s requests. In the
regional group’s member countries, the medicines are distributed by
health experts from the
island participating in different humanitarian programs underway in
those nations.
The installed capacity of the labs is of 34 million bottles a year,
of which 87 to 90
percent is annually met, Alarcon Camejo explained and added that in
2009 29,7 million units
were produced, including a new digestive suspension that was
produced for the first time
during the recently concluded year.
He added that for 2010, they expect to increase the output by eight
percent as compared to
2009 and beat the record of a total of 30 million units reached in
2008.
